Resistance to parasitic protozoa appears to be similar to resistance against other infectious agents, although the mechanisms of resistance in protozoan infections are not yet as well understood. Resistance can be divided into two main groups of mechanisms: (1) nonspecific mechanism(s) or factor(s) such as the presence of a nonspecific serum component that is lethal to the parasite; and (2) specific mechanism(s) involving the immune system (Fig. 78-1). Probably the best studied nonspecific mechanisms involved in parasite resistance are the ones that control the susceptibility of red blood cells to invasion or growth of plasmodia, the agents of malaria. Individuals who are heterozygous or homozygous for the sickle cell hemoglobin trait are considerably more resistant to than are individuals with normal hemoglobin. Similarly, individuals who lack the Duffy factor on their red blood cells are not susceptible to . Possibly both the sickle cell trait and absence of the Duffy factor have become established in malaria-endemic populations as a result of selective pressure exerted by malaria. Epidemiologic evidence suggests that other inherited red blood cell abnormalities, such as thalassanemia and glucose-6-phosphate dehydrogenase deficiency, may contribute to survival of individuals in various malaria-endemic geographical regions. A second well-documented example of a nonspecific factor involved in resistance is the presence in the serum of humans of a trypanolytic factor that confers resistance against , an agent of trypanosomiasis (sleeping sickness) in animals. There is evidence that other nonspecific factors, such as fever and the sex of the host, may also contribute to the host's resistance to various protozoan parasites. Although nonspecific factors can play a key role in resistance, usually they work in conjunction with the host's immune system (Fig. 78-1). Different parasites elicit different humoral and/or cellular immune responses. In malaria and trypanosome infections, antibody appears to play a major role in immunity. In both and infections, antibody-dependent cytotoxic reactions against the parasite have been reported. Although antibody has been shown to be responsible for clearing the African trypanosomes from the blood of infected animals, recent evidence suggests that the survival time of infected mice does not necessarily correlate with the ability of the animal to produce trypanosome-specific antibody. In other words, resistance as measured by survival time may not solely involve the specific humoral immune system. Recent data suggest that cellular immunity is required for resistance to malaria. for example, vaccine trials with a sporozoite antigen indicated that both an active cellular response and sporozoite-specific antibody may be needed for successful immunization. Cellular immunity is believed to be the single most important defense mechanism in leishmaniasis and toxoplasmosis. In animals infected with , the activated macrophage has been shown to play an important role in resistance. Accordingly, resistance to the protozoan parasites most likely involves nonspecific factors as well as specific humoral and/or cellular mechanisms. Cytokines are involved in the control of both the immune response and pathology. It has become apparent that there are subsets of both helper (h) and cytotoxic (c) T-cells that produce different profiles of cytokines. For example, the Th-1 subset produces gamma interferon (IFN-α), and interleukin-2 (IL-2) and is involved in cell-mediated immunity. In contrast the Th-2 subset produces IL-4 and IL-6, and is responsible for antibody-mediated immunity. The induction of a particular T-cell subset is key to recovery and resistance. The Th-1 subset and increased IFN-g are important in resistance to , and infections, whereas the Th-2 response is more important in parasitic infections in which antibody is a key factor. It is important to recognize that the cytokines produced by one T-cell subset can up or downregulate the response of other T-cell subsets. IL-4 will downregulate Th-1 cells and exacerbate infection and/or susceptibility of mice to . The cytokines produced by T and other cell types do not act directly on the parasites but influence other host cell types. The response of cells to cytokines includes a variety of physiological changes, such as changes in glucose, fatty acid and protein metabolism. For example, IL-1 and tumor necrosis factor will increase gluconeogenesis, and glucose oxidation. It should be noted that cytokines influence the metabolism not only of T-cells, but also a variety of other cell types and organ systems. Cytokines can also stimulate cell division and, therefore, clonal expansion of T and B-cell subsets. This can lead to increased antibody production and/or cytotoxic T-cell numbers. The list of cytokines and their functions is growing rapidly, and it would appear that these chemical messages influence all phases of the immune response. they are also clearly involved in the multitude of physiological responses (fever, decreased food intake, etc.) observed in an animal's response to a pathogen, and in the pathology that results. Unlike most viral and bacterial infections, protozoan diseases are often chronic, lasting months or years. When associated with a strong host immune response, this type of chronic infection is apt to result in a high incidence of immunopathology. The question also arises of how these parasites survive in an immunocompetent animal. The remainder of this chapter treats the mechanisms responsible for pathology, particularly immunopathology, in protozoan disease, and the mechanisms by which parasites evade the immune responses of the host. Finally, because of the very rapid advances in our knowledge of the host-parasite relationship (due primarily to the development of techniques in molecular biology), it is necessary to briefly mention the potential for developing vaccines to the pathogenic protozoa.
对寄生原生动物的抗性似乎与对其他感染因子的抗性相似,尽管原生动物感染中的抗性机制尚未得到充分了解。抗性可分为两大类机制:(1)非特异性机制或因素,如存在对寄生虫具有致死性的非特异性血清成分;(2)涉及免疫系统的特异性机制(图78-1)。可能研究得最充分的与寄生虫抗性相关的非特异性机制是那些控制红细胞对疟原虫(疟疾病原体)入侵或生长易感性的机制。镰状细胞血红蛋白性状的杂合子或纯合子个体比正常血红蛋白个体对疟疾的抗性要强得多。同样,红细胞上缺乏达菲因子的个体不易感染疟原虫。镰状细胞性状和达菲因子的缺失可能都是由于疟疾施加的选择压力而在疟疾流行人群中确立的。流行病学证据表明,其他遗传性红细胞异常,如地中海贫血和葡萄糖-6-磷酸脱氢酶缺乏症,可能有助于个体在不同疟疾流行地理区域的生存。另一个有充分记录的与抗性相关的非特异性因素的例子是人类血清中存在一种锥虫溶解因子,它赋予对布氏锥虫(动物锥虫病(昏睡病)的病原体)的抗性。有证据表明,其他非特异性因素,如发热和宿主性别,也可能有助于宿主对各种原生动物寄生虫的抗性。虽然非特异性因素在抗性中可以发挥关键作用,但它们通常与宿主的免疫系统协同作用(图78-1)。不同的寄生虫引发不同的体液和/或细胞免疫反应。在疟疾和锥虫感染中,抗体似乎在免疫中起主要作用。在疟原虫和锥虫感染中,都有针对寄生虫的抗体依赖性细胞毒性反应的报道。虽然抗体已被证明负责从感染动物的血液中清除非洲锥虫,但最近的证据表明,感染小鼠的存活时间不一定与动物产生锥虫特异性抗体的能力相关。换句话说,以存活时间衡量的抗性可能不仅仅涉及特异性体液免疫系统。最近的数据表明,对疟疾的抗性需要细胞免疫。例如,用子孢子抗原进行的疫苗试验表明,成功免疫可能需要活跃的细胞反应和子孢子特异性抗体。细胞免疫被认为是利什曼病和弓形虫病中最重要的单一防御机制。在感染利什曼原虫的动物中,活化的巨噬细胞已被证明在抗性中起重要作用。因此,对原生动物寄生虫的抗性很可能涉及非特异性因素以及特异性体液和/或细胞机制。细胞因子参与免疫反应和病理的控制。已经很明显,辅助性(h)和细胞毒性(c)T细胞都有亚群,它们产生不同的细胞因子谱。例如,Th-1亚群产生γ干扰素(IFN-α)和白细胞介素-2(IL-2),并参与细胞介导的免疫。相比之下,Th-2亚群产生IL-4和IL-6,并负责抗体介导的免疫。特定T细胞亚群的诱导是恢复和抗性的关键。Th-1亚群和增加的IFN-γ在对疟原虫、利什曼原虫和锥虫感染的抗性中很重要,而Th-2反应在抗体是关键因素的寄生虫感染中更重要。重要的是要认识到,一个T细胞亚群产生的细胞因子可以上调或下调其他T细胞亚群的反应。IL-4会下调Th-1细胞,并加剧小鼠对利什曼原虫的感染和/或易感性。T细胞和其他细胞类型产生的细胞因子不会直接作用于寄生虫,而是影响其他宿主细胞类型。细胞对细胞因子的反应包括多种生理变化,如葡萄糖、脂肪酸和蛋白质代谢的变化。例如,IL-1和肿瘤坏死因子会增加糖异生和葡萄糖氧化。应该注意的是,细胞因子不仅影响T细胞的代谢,还影响多种其他细胞类型和器官系统。细胞因子还可以刺激细胞分裂,因此刺激T和B细胞亚群的克隆扩增。这可以导致抗体产生增加和/或细胞毒性T细胞数量增加。细胞因子及其功能的清单正在迅速增加,这些化学信号似乎影响免疫反应的所有阶段。它们也明显参与动物对病原体反应中观察到的多种生理反应(发热、食物摄入量减少等)以及由此导致的病理过程。与大多数病毒和细菌感染不同,原生动物疾病通常是慢性的,持续数月或数年。当与强烈的宿主免疫反应相关时,这种慢性感染容易导致免疫病理学的高发病率。还出现了这些寄生虫如何在免疫功能正常的动物中存活的问题。本章其余部分讨论原生动物疾病中负责病理,特别是免疫病理的机制,以及寄生虫逃避宿主免疫反应的机制。最后,由于我们对宿主-寄生虫关系的认识迅速发展(主要由于分子生物学技术的发展),有必要简要提及开发针对致病性原生动物的疫苗的潜力。